Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 301–400 of 797
Neural Stem Cells Maintain Their Stemness through Protein Kinase C ζ-Mediated Inhibition of TRIM32
Hillje, A., Worlitzer, M. M. A., Palm, T., & Schwamborn, J. C. (2011) · Stem Cells · doi:10.1002/stem.687 · Cited by 58
Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice
Jung, C., Lim, J. H., Choi, Y., Kim, D., Kang, K. J., Noh, S., & Im, D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42674 · Cited by 62
Nanoreceptors promote mutant p53 protein degradation by mimicking selective autophagy receptors
Huang, X., Cao, Z., Qian, J., Ding, T., Wu, Y., Zhang, H., Zhong, S., Wang, X., Ren, X., Zhang, W., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-023-01562-5 · Cited by 69
“To evaluate whether the ubiquitination affected the degradation process or the recognition of mutp53 by NRs, we assessed the binding propensity of NRs to mutp53 proteins ubiquitinated in vitro 31,32 .”
The evolution of MDM2 family genes
Momand, J., Villegas, A., & Belyi, V. A. (2011) · Gene · doi:10.1016/j.gene.2011.06.030 · Cited by 45
Pirh2 RING‐finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy
Jung, Y.-S., Qian, Y., & Chen, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.052 · Cited by 57
“In addition to polyubiquitinating p53, Mdm2 mediates p53 monoubiquitination leading to nuclear export of p53 [41].”
BackgroundMisfolding, Aggregation, and Disordered Segments in c-Abl and p53 in Human Cancer
de Oliveira, G. A. P., Rangel, L. P., Costa, D. C., & Silva, J. L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00097 · Cited by 53
“Otherwise, poly-ubiquitination occurs, which acts as a signal for degradation in the nucleus or cytoplasm (89).”
BackgroundDutta, D., Chakraborty, S., Bandyopadhyay, C., Veettil, M. V., Ansari, M. A., Singh, V. V., & Chandran, B. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003510 · Cited by 60
“Moreover, the fate of internalized receptors also varies with the pattern of ubiquitination [31,32].”
BackgroundRay, S., Zhao, Y., Jamaluddin, M., Edeh, C. B., Lee, C., & Brasier, A. R. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.007 · Cited by 54
Geng, Y., Walls, K. C., Ghosh, A. P., Akhtar, R. S., Klocke, B. J., & Roth, K. A. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954024 · Cited by 58
“Phosphorylation and acetylation of p53 sequester p53 in the nucleus (Appella and Anderson 2001), whereas monoubiquitination of p53 leads to its nuclear export (Li et al. 2003) or mitochondrial translocation.”
Nipah virus matrix protein: expert hacker of cellular machines
Watkinson, R. E., & Lee, B. (2016) · FEBS Letters · doi:10.1002/1873-3468.12272 · Cited by 59
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira, N., & Yoshida, K. (2012) · PubMed · doi:10.14670/hh-27.437 · Cited by 61
“Importantly, MDM2 cellular expression determines whether MDM2 induces p53 destruction or nuclear export (Li et al., 2003).”
BackgroundSasaki, M., Nie, L., & Maki, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610514200 · Cited by 53
Runt-Related Transcription Factor RUNX3 Is a Target of MDM2-Mediated Ubiquitination
Chi, X., Kim, J., Lee, Y.-H., Lee, J.-W., Lee, K., Wee, H., Kim, W., Park, W., Oh, B., Stein, G. S., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1057 · Cited by 57
Nucleolar control of p53: a cellular Achilles’ heel and a target for cancer therapy
Vlatković, N., Boyd, M. T., & Rubbi, C. P. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1361-x · Cited by 57
Modifications of p53: competing for the lysines
Carter, S. A., & Vousden, K. H. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.010 · Cited by 72
Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma
Becker, K., Marchenko, N. D., Maurice, M., & Moll, U. M. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402126 · Cited by 45
“Although polyubiquitylated p53 is unstable due to rapid proteasomal degradation, (multi)monoubiquitylated p53 is stable and results in nuclear exclusion.(21) p53 ubiquitylation is reversible by the p53 deubiquitylating enzyme HAUSP (herpes virus-associated ubiquitin-specific protease), resulting in p53 stabilization,…”
BackgroundResultDeciphering the PTM codes of the tumor suppressor p53
Wen, J., & Wang, D. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab047 · Cited by 59
“Remarkably, MDM2 can catalyze both mono- and polyubiquitination of p53 depending on its level: a low level of MDM2 induces monoubiquitination, which triggers cytoplasmic translocation of p53, whereas a high level of MDM2 leads to degradation of polyubiquitinated p53 (Li et al., 2003).”
BackgroundNuclear proteins acting on mitochondria
Lindenboim, L., Borner, C., & Stein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.11.016 · Cited by 56
Liu, D., Cui, L., Wang, Y., Yang, G., He, J., Hao, R., Fan, C., Qu, M., Liu, Z., Wang, M., et al. (2016) · Hepatology · doi:10.1002/hep.28594 · Cited by 54
“Ubiquitination of p53 by HDM2 may induce p53 translocation from nucleus to cytoplasm.((8,11,12)) Ectopic expression of wt p53 fused to enhanced green fluorescent protein (EGFP) yielded predominantly nuclear localization of p53 in Hep3B cells (Fig.”
BackgroundResultLow temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro
Sakurai, T., Itoh, K., Liu, Y., Higashitsuji, H., Sumitomo, Y., Sakamaki, K., & Fujita, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.06.002 · Cited by 52
Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation
Siepe, D. H., & Jentsch, S. (2009) · Nature Cell Biology · doi:10.1038/ncb1908 · Cited by 53
“Inhibition of Pin1 in mammalian cells changes the ubiquitylation status of the tumour suppressor protein p53 from oligoubiquitylation, which is known to trigger nuclear expor”
BackgroundA novel ARF-binding protein (LZAP) alters ARF regulation of HDM2
Wang, J., He, X., Luo, Y., & Yarbrough, W. G. (2005) · Biochemical Journal · doi:10.1042/bj20050960 · Cited by 55
Ubiquitin and control of transcription
Dhananjayan, S. C., Ismail, A., & Nawaz, Z. (2005) · Essays in Biochemistry · doi:10.1042/bse0410069 · Cited by 64
“Mdm2 at low levels preferentially monoubquitinates p53, which leads to its nuclear exclusion, whereas at high levels of Mdm2, p53 is polyubiquitinated and marked for degradation by the 26 S proteasome [40,41].”
BackgroundShmueli, A., & Oren, M. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00529-x · Cited by 58
Zinc deficiency causes neural tube defects through attenuation of p53 ubiquitylation
Li, H., Zhang, J., & Niswander, L. A. (2018) · Development · doi:10.1242/dev.169797 · Cited by 56
“The E3 ubiquitin ligase Mdm2 ubiquitylates p53, which drives it to D E V E LO P M E N T the proteasome for degradation; conversely, the deubiquitylation enzyme Hausp removes ubiquitin and stabilizes p53 (Cheng et al., 2011; Haupt et al., 1997; Li et al., 2003; Li et al., 2002; Ma et al., 2010).”
BackgroundUbiquitination by TOPORS Regulates the Prostate Tumor Suppressor NKX3.1
Guan, B., Pungaliya, P., Li, X., Uquillas, C. A., Mutton, L. N., Rubin, E. H., & Bieberich, C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708630200 · Cited by 51
Targeting the ubiquitin–proteasome system to activate wild-type p53 for cancer therapy
Allende-Vega, N., & Saville, M. K. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.004 · Cited by 52
Posttranslational modification of mammalian AP endonuclease (APE1)
Busso, C. S., Lake, M. W., & Izumi, T. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0487-3 · Cited by 50
“[94] reported that p53 was polyubiquitinated rather than monoubiquitinated when the intracellular concentration of MDM2 was higher.”
Rodríguez, J. E., Liao, J.-Y., He, J., Schisler, J. C., Newgard, C. B., Drujan, D., Glass, D. J., Frederick, C. B., Yoder, B. C., Lalush, D. S., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.008 · Cited by 50
“These studies parallel recent findings in cancer, whereby the ubiquitin ligase MDM2 was found to monoubiquitinate p53 to target its nuclear export (Li et al., 2003).”
Luo, M., Koh, M., Feng, J., Wu, Q., & Melamed, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7386-7398.2005 · Cited by 53
“The molecular mechanisms involved in differentiating between mono- and polyubiquitylation have yet to be defined, and although a recent report suggested the concentration of the E3 ligase could be the determinant ( 29 ), the latter may well also require additional enzymes, such as E4 ligases involved in promoting chai…”
BackgroundNoncanonical K27-Linked Polyubiquitination of TIEG1 Regulates Foxp3 Expression and Tumor Growth
Peng, D.-J., Zeng, M., Muromoto, R., Matsuda, T., Shimoda, K., Subramaniam, M., Spelsberg, T. C., Wei, W., & Venuprasad, K. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003801 · Cited by 56
Natarajan, T. G., Kallakury, B., Sheehan, C. E., Bartlett, M. B., Ganesan, N., Preet, A., Ross, J. S., & Fitzgerald, K. T. (2010) · Cancer Cell International · doi:10.1186/1475-2867-10-13 · Cited by 56
“Nuclear-Cytoplasmic fractionation Equal volumes of the cell pellet from each cell line were used for fractionation following an established protocol [28].”
MethodDung, T. D., Day, C. H., Binh, T. V., Lin, C., Hsu, H.-H., Su, C., Lin, Y.-M., Tsai, F., Kuo, W., Chen, L.-M., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.01.021 · Cited by 50
Carotenoid-Induced Cooperative Formation of Bacterial Photosynthetic LH1 Complex
Fiedor, L., Akahane, J., & Koyama, Y. (2004) · Biochemistry · doi:10.1021/bi0481287 · Cited by 49
Rinaldo, C., Prodosmo, A., Siepi, F., Moncada, A., Sacchi, A., Selivanova, G., & Soddu, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0337 · Cited by 51
Autophagy-Related Deubiquitinating Enzymes Involved in Health and Disease
Magraoui, F. E., Reidick, C., Meyer, H. E., & Platta, H. W. (2015) · Cells · doi:10.3390/cells4040596 · Cited by 52
“stabilization [79] and protection against degradation by Mdm2 or another E3 enzyme [93].”
BackgroundSUMO and Nucleocytoplasmic Transport
Ptak, C. P., & Wozniak, R. W. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-50044-7_7 · Cited by 53
“An example is the nuclear export of mammalian p53, which requires its monoubiquitination ( Li et al., 2003 ).”
BackgroundYu, W., Qiu, Z., Gao, N., Wang, L., Cui, H., Qian, Y., Jiang, L., Luo, J., Yi, Z., Lu, H., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1117 · Cited by 55
Saha, T., Ghosh, S., Vassilev, A. P., & Depamphilis, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.02851 · Cited by 48
“1(TOPO, His-HA-UbKO) (Li et al., 2003).”
BackgroundMechanistic Studies of MDM2-mediated Ubiquitination in p53 Regulation
Brooks, C. L., Li, M., & Gu, W. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700961200 · Cited by 48
Self-citationRegulation of neuronal P53 activity by CXCR4
Khan, M. Z., Shimizu, S., Patel, J. P., Nelson, A., Le, M.-T., Mullen-Przeworski, A., Brandimarti, R., Fatatis, A., & Meucci, O. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.05.007 · Cited by 52
Jin, X., Chandrakanthan, V., Morgan, H. D., & O’Neill, C. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.108.070102 · Cited by 47
“The interactions between MDM2 and TRP53 are complex, and different modes of regulation may occur, depending upon the stoichiometric relationship between these two autoregulatory partners [53].”
BackgroundLiu, J., Zou, X., Gotoh, T., Brown, A. M., Jiang, L., Wisdom, E. L., Kim, J. K., & Finkielstein, C. V. (2018) · Science Signaling · doi:10.1126/scisignal.aau0715 · Cited by 52
“11, eaau0715 (2018) 13 November 2018 13 of 17 circadian proteins, posttranslational modifications of this nature by MDM2 are not uncommon as shown, for example, in the case of p53 and FOXO4 (41, 65).”
BackgroundInfluentialFrustrated bistability as a means to engineer oscillations in biological systems
Krishna, S., Semsey, S., & Jensen, M. H. (2009) · Physical Biology · doi:10.1088/1478-3975/6/3/036009 · Cited by 50
“(3) B could directly interact with A and target it for degradation, for instance by tagging it with a ubiquitin molecule, which is how Mdm2 acts on p53 [30].”
BackgroundArora, S., Yang, J., & Hait, W. N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4036 · Cited by 48
The Circadian Protein PER1 Modulates the Cellular Response to Anticancer Treatments
Bellet, M. M., Stincardini, C., Costantini, C., Gargaro, M., Pieroni, S., Castelli, M., Piobbico, D., Sassone‐Corsi, P., Fazia, M. A. D., Romani, L. R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062974 · Cited by 50
“Given the control of PER1 on p53 at the post-translational level, we analyzed a putative role played by MDM2, the most important negative regulator of p53 in controlling p53 stability [12].”
BackgroundRodríguez, J. A. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.03.005 · Cited by 51
Modulation of p53 C-Terminal Acetylation by mdm2, p14ARF, and Cytoplasmic SirT2
van Leeuwen, I. M. M., Higgins, M., Campbell, J., McCarthy, A. R., Sachweh, M. C. C., Navarro, A. M., & Laín, S. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0904 · Cited by 46
“polyubiquitinated and subsequently degraded by the proteasome (37).”
BackgroundNew p53 target, phosphatase of regenerating liver 1 (PRL-1) downregulates p53
Min, S.-H., Deuk‐Su, K. I. M., Heo, Y.-S., Kim, Y., Kim, H., Kim, J., Han, Y.-M., Kim, I.-C., & Yoo, O.-J. (2008) · Oncogene · doi:10.1038/onc.2008.409 · Cited by 48
He, J., Quintana, M. T., Sullivan, J., Parry, T. L., Grevengoed, T. J., Schisler, J. C., Hill, J. A., Yates, C. C., Mapanga, R. F., Essop, M. F., et al. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0252-x · Cited by 48
“In these series of elegant studies, investigators identified that low levels of MDM2 induced mono-ubiquitination and nuclear export of p53, whereas high levels of MDM2 promoted poly-ubiquitination and nuclear degradation of p53 [90].”
BackgroundThalappilly, S., Feng, X., Pastyryeva, S., Suzuki, K., Muruve, D. A., Larocque, D., Richard, S., Truß, M., von Deimling, A., Riabowol, K. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021065 · Cited by 50
Kamat, C. D., Shmueli, R. B., Connis, N., Rudin, C. M., Green, J. J., & Hann, C. L. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0956 · Cited by 45
Dynamin Interacts with Members of the Sumoylation Machinery
Mishra, R. K., Jatiani, S., Kumar, A., Simhadri, V. R., Hosur, R. V., & Mittal, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402911200 · Cited by 47
Chakraborty, S., Veettil, M. V., Sadagopan, S., Paudel, N., & Chandran, B. (2011) · Journal of Virology · doi:10.1128/jvi.05953-11 · Cited by 48
“Ubiquitination of receptors has been recognized as an internalization signal, and more importantly, the fate of receptors upon internalization varies with the pattern of ubiquitination (20, 25).”
Backgroundp53 stabilization: the importance of nuclear import
Marine, J. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2009.183 · Cited by 44
Wienken, M., Moll, U. M., & Dobbelstein, M. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw046 · Cited by 49
“Furthermore, Mdm2 inhibits p53mediated transactivation and also controls its cellular localization (Momand et al., 1992; Roth et al., 1998; Li et al., 2003).”
A universal strategy for stable intracellular antibodies
Loewenstein, S., Zfania, R., Hyland, S. N., Wels, W. S., & Benhar, I. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.05.004 · Cited by 46
TP53 alterations of hormone-naïve prostate cancer in the Chinese population
Liu, Z., Guo, H., Zhu, Y., Xia, Y., Cui, J., Shi, K., Fan, Y., Shi, B., & Chen, S. (2020) · Prostate Cancer and Prostatic Diseases · doi:10.1038/s41391-020-00302-3 · Cited by 42
Delker, R. K., Zhou, Y., Strikoudis, A., Stebbins, C. E., & Papavasiliou, F. N. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214538110 · Cited by 50
“This result could also represent the conversion of a single monoubiquitylation event to polyubiquitylation due to E3 ligase overexpression, which has been demonstrated for Mdm2 and p53 (25).”
BackgroundUbiquitin Signals Proteolysis-Independent Stripping of Transcription Factors
Ndoja, A., Cohen, R. E., & Yao, T. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.02.002 · Cited by 50
“Depending on the activator, monoubiquitination (mono-Ub) or oligo-ubiquitination can promote either nuclear localization (van der Horst et al., 2006) or nuclear export (Li et al., 2003).”
Wachter, F., Morgan, A. M., Godes, M., Mourtada, R., Bird, G. H., & Walensky, L. D. (2016) · Oncogene · doi:10.1038/onc.2016.361 · Cited by 48
Is p53 Involved in Tissue‐Specific Insulin Resistance Formation?
Strycharz, J., Drzewoski, J., Szemraj, J., & Śliwińska, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9270549 · Cited by 50
“MDM2-dependent p53 monoubiquitination mediates nuclear exclusion of p53 and precludes its transcriptional activity [54].”
BackgroundMitochondrial–nuclear p53 trafficking controls neuronal susceptibility in stroke
Almeida, Á., Sánchez‐Morán, I., & Rodríguez, C. (2021) · IUBMB Life · doi:10.1002/iub.2453 · Cited by 45
“Lysine residues at the C-terminal domain of p53 are the main sites of MDM2-induced ubiquitination.(8) However, low levels of MDM2 monoubiquitinates p53, driving its chromosomal region maintenance 1 (CRM1)-dependent nuclear export.”
BackgroundSenescence-inducing stress promotes proteolysis of phosphoglycerate mutase via ubiquitin ligase Mdm2
Mikawa, T., Maruyama, T., Okamoto, K., Nakagama, H., LLeonart, M. E., Tsusaka, T., Hori, K., Murakami, I., Izumi, T., Takaori‐Kondo, A., et al. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201306149 · Cited by 51
“7 A and Lipkowitz and Weissman, 2011).”
Impact of TP53 mutations in Triple Negative Breast Cancer
Mitri, Z. I., Abuhadra, N. K., Goodyear, S. M., Hobbs, E. A., Kaempf, A. J., Thompson, A. M., & Moulder, S. L. (2022) · npj Precision Oncology · doi:10.1038/s41698-022-00303-6 · Cited by 60
p53 regulation upon genotoxic stress: intricacies and complexities
Kumari, R., Kohli, S., & Das, S. (2014) · Molecular & Cellular Oncology · doi:10.4161/23723548.2014.969653 · Cited by 53
“Low levels of MDM2 monoubiquitylate p53 and result in its sequestration in the cytoplasm.(71) MSL2 specifically monoubiquitylates K351 and K357 of p53 independent of MDM2, and mediates its nuclear export.”
BackgroundMDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function
Wu, H., & Leng, R. P. (2015) · Oncotarget · doi:10.18632/oncotarget.4086 · Cited by 48
“It has been reported that low level of MDM2 induces monoubiquitination of p53, whereas high level of MDM2 promotes polyubiquitination of p53 [25].”
Swetzig, W. M., Wang, J., & Das, G. M. (2016) · Oncotarget · doi:10.18632/oncotarget.7533 · Cited by 53
The Role of MDM2 in Promoting Genome Stability versus Instability
Saadatzadeh, M., Elmi, A., Pandya, P., Bijangi-Vishehsaraei, K., Ding, J., Stamatkin, C., Cohen-Gadol, A., & Pollok, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102216 · Cited by 41
“MDM2 directly interacts with p53, facilitates the transport of p53 from the nucleus to cytoplasm, and monoubiquitinates, or in some instances, multi-monoubiquitinates p53 [30].”
BackgroundNam, G. H., Jo, K.-J., Park, Y.-S., Kawk, H. W., Kim, S.-Y., & Kim, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00406 · Cited by 50
The dynamics of p53 in single cells: physiologically based ODE and reaction–diffusion PDE models
Eliaš, J., Dimitrio, L., Clairambault, J., & Natalini, R. (2014) · Physical Biology · doi:10.1088/1478-3975/11/4/045001 · Cited by 41
MDM2 Promotes Proteasomal Degradation of p21Waf1 via a Conformation Change
Xu, H., Zhang, Z., Li, M., & Zhang, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059568 · Cited by 45
Rubio-Villena, C., García-Gimeno, M. A., & Sanz, P. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.019 · Cited by 41
“…enzymes involved in glycogen homeostasis: they bind glycogen synthase (GS), allowing in this way the dephosphorylation of the synthase and its activation; they also bind glycogen phosphorylase (Ph) and glycogen phosphorylase kinase (PhK), allowing the dephosphorylation and inactivation of…”
BackgroundMethodInfluentialA high-content chemical screen identifies ellipticine as a modulator of p53 nuclear localization
Xu, G. W., Mawji, I. A., Macrae, C. J., Koch, C. A., Datti, A., Wrana, J. L., Dennis, J. W., & Schimmer, A. D. (2008) · APOPTOSIS · doi:10.1007/s10495-007-0175-4 · Cited by 47
“Ubiquitination of p53, via the E3 ligase activity of MDM2, promotes p53 nuclear export [30, 31].”
BackgroundMonoubiquitination Inhibits the Actin Bundling Activity of Fascin
Lin, S., Lu, S., Mulaj, M., Fang, B., Keeley, T. S., Wan, L., Hao, J., Muschol, M., Sun, J., & Yang, S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.767640 · Cited by 44
ARF-BP1 as a potential therapeutic target
Chen, D., Brooks, C. L., & Gu, W. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603119 · Cited by 49
“First, while the low levels of Mdm2 that are commonly observed in normal cells preferentially catalyse monoubiquitination of p53 (Li et al, 2003), ARF can not inhibit Mdm2-mediated monoubiquitination of p53 in vivo, although it can block p53 polyubiquitination (Xirodimas et al, 2001).”
BackgroundSelf-citationZhang, X., Turnell, A. S., Gorbea, C. M., Mymryk, J. S., Gallimore, P. H., & Grand, R. J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403287200 · Cited by 41
Katayama, A., Ogino, T., Bandoh, N., Takahara, M., Kishibe, K., Nonaka, S., & Harabuchi, Y. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.3.517 · Cited by 40
Moreira, J., Almeida, J., Saraiva, L., Cidade, H. M., & Pinto, M. M. M. (2021) · Molecules · doi:10.3390/molecules26123737 · Cited by 54
“In addition to it ubiquitination property and proteasomal degradation, MDM2 inhibits the tra scription tivity of p53 (Figu 2) [15].”
BackgroundShcherbik, N., & Haines, D. S. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20130 · Cited by 39
“MDM2 has recently been shown to promote mono-ubiquitination of p53 at low ratios and poly-ubiquitination at high ratios [Li et al., 2003].”
BackgroundDistinct Ubiquitination Cascades Act on the Peroxisomal Targeting Signal Type 2 Co‐receptor Pex18p
Magraoui, F. E., Brinkmeier, R., Schrötter, A., Girzalsky, W., Müller, T., Marcus, K., Meyer, H. E., Erdmann, R., & Platta, H. W. (2013) · Traffic · doi:10.1111/tra.12120 · Cited by 37
Dai, C., Shi, D., & Gu, W. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.476606 · Cited by 43
“Cell-based Ubiquitination Assay—Cell-based ubiquitination assays were performed essentially as described (58) with some modifications.”
MethodSelf-citationL-GILZ binds p53 and MDM2 and suppresses tumor growth through p53 activation in human cancer cells
Ayroldi, E., Petrillo, M. G., Bastianelli, A., Marchetti, M. C., Ronchetti, S., Nocentini, G., Ricciotti, L., Cannarile, L., & Riccardi, C. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.129 · Cited by 44
“ligase that promotes p53 monoubiquitination and nuclear export as well as polyubiquitination and degradation.(44,45) Although MDM2 can be degraded via autoubiquitination,(46)”
BackgroundRoukens, M. G., Alloul‐Ramdhani, M., Moghadasi, S., den Brouw, M. O., & Baker, D. A. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01914-07 · Cited by 41
Frazier, D. P., Kendig, R. D., Kai, F., Maglic, D., Sugiyama, T., Morgan, R. L., Fry, E. A., Lagedrost, S. J., Sui, G., & Inoue, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2410 · Cited by 46
“Li et al demonstrated that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53’s polyubiquitination and nuclear degradation (31).”
MDM2 facilitates adipocyte differentiation through CRTC-mediated activation of STAT3
Hallenborg, P., Siersbæk, M. S., Barrio‐Hernandez, I., Nielsen, R., Kristiansen, K., Mandrup, S., Grøntved, L., & Blagoev, B. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.188 · Cited by 41
“ubiquitination of p53 and only at high levels MDM2 polyubiquitinates p53.(48)”
BackgroundStructural basis for DNA damage-induced phosphoregulation of MDM2 RING domain
Magnussen, H. M., Ahmed, S. F., Sibbet, G. J., Hristova, V. A., Nomura, K., Hock, A. K., Archibald, L. J., Jamieson, A. G., Fushman, D., Vousden, K. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15783-y · Cited by 38
Moore, L. M., Lu, X., Ghebranious, N., Tyner, S. D., & Donehower, L. A. (2007) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.10.011 · Cited by 40
Cui, S., Hu, H., Chen, A., Cui, M., Pan, X., Zhang, P., Wang, G., Wang, H., & Hao, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.08.019 · Cited by 41
MDM2 and MDMX in Cancer and Development
Marine, J. (2011) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-380916-2.00003-6 · Cited by 42
Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing Family Tumors
Li, Y., Li, X., Fan, G.-Y., Fukushi, J., Matsumoto, Y., Iwamoto, Y., & Zhu, Y. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.01.018 · Cited by 46
Switching on p53: an essential role for protein phosphorylation?
Loughery, J., & Meek, D. W. (2013) · Biodiscovery · doi:10.7750/biodiscovery.2013.8.1 · Cited by 49
Tp53 and its potential therapeutic role as a target in bladder cancer
Ciccarese, C., Massari, F., Blanca, A., Tortora, G., Montironi, R., Cheng, L., Scarpelli, M., Raspollini, M. R., Vau, N., Fonseca, J., et al. (2017) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1297798 · Cited by 42
“This study proposed that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53’s polyubiquitination and nuclear degradation [9].”
BackgroundJab1 as a Mediator of Nuclear Export and Cytoplasmic Degradation of p53
Lee, E., Oh, W., & Song, J. (2006) · Molecules and Cells · doi:10.1016/s1016-8478(23)17401-2 · Cited by 42
Stewart, D., Ghosh, A., & Matlashewski, G. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8773-8783.2005 · Cited by 43
“Nuclear enriched fractions were prepared as previously described ( 20 ), with minor changes.”
BackgroundInfluentialChen, Z., Knutson, E. P., Wang, S., Martinez, L. A., & Albrecht, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705349200 · Cited by 39
Schmidt, C., Breyer, F., Blum, M., Thiermann, H., Worek, F., & John, H. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-7706-y · Cited by 37
Regulation of large and small G proteins by ubiquitination
Dohlman, H. G., & Campbell, S. L. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.011068 · Cited by 40
“Other prominent examples include the human tumor suppressor p53 (32) and the proliferating cell nuclear antigen (33).”
BackgroundHAUSP as a therapeutic target for hematopoietic tumors (review)
Cheon, K., & Baek, K.-H. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.5.1209 · Cited by 37
Polycomb Group Protein PHF1 Regulates p53-dependent Cell Growth Arrest and Apoptosis
Yang, Y., Wang, C., Zhang, P., Gao, K., Wang, D., Yu, H., Zhang, T., Jiang, S., Hexige, S., Hong, Z., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338996 · Cited by 41
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.